Fluvoxamine serum concentrations in children and adolescents - preliminary results of a multicenter Therapeutic Drug Monitoring (TDM) trial

被引：0
|
作者：
Taurines, R. [1 ]
Kunkel, G. [1 ]
Fekete, S. [1 ]
Gerlach, M.
Romanos, M. [1 ]
Egberts, K. [1 ]
机构：
[1] Univ Hosp Wuerzburg, Dept Child & Adolescent Psychiat Psychosomat & Ps, Ctr Mental Hlth, Wurzburg, Germany
[2] TDM VIGIL Konsortium, Tubingen, Germany
来源：
PHARMACOPSYCHIATRY | 2024年 / 57卷 / 02期
关键词：
D O I：
10.1055/s-0044-1779580
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
37
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [1] Venlafaxine serum concentrations in children and adolescents - preliminary results of a multicenter Therapeutic Drug Monitoring trial
    Ortmann, C.
    Fekete, S.
    Taurines, R.
    Gerlach, M.
    Romanos, M.
    Egberts, K.
    PHARMACOPSYCHIATRY, 2024, 57 (02) : 91 - 91
  • [2] Therapeutic drug monitoring (TDM) of fluoxetine in children and adolescents
    Koelch, M.
    Pfalzer, A.
    Keller, F.
    Plener, P.
    Gerlach, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S608 - S609
  • [3] Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
    Hansen, D.
    Taurines, R.
    Wewetzer, C.
    Pfuhlmann, B.
    Plener, P.
    Mehler-Wex, C.
    Gerlach, M.
    Egberts, K.
    PHARMACOPSYCHIATRY, 2012, 45 (06) : 253 - 253
  • [4] Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial
    Frey, Michael
    Smigielski, Lukasz
    Tini, Elvira
    Fekete, Stefanie
    Fleischhaker, Christian
    Wewetzer, Christoph
    Karwautz, Andreas
    Correll, Christoph U.
    Gerlach, Manfred
    Taurines, Regina
    Plener, Paul L.
    Malzahn, Uwe
    Kornbichler, Selina
    Weninger, Laura
    Brockhaus, Matthias
    Reuter-Dang, Su-Yin
    Reitzle, Karl
    Rock, Hans
    Imgart, Hartmut
    Heuschmann, Peter
    Unterecker, Stefan
    Briegel, Wolfgang
    Banaschewski, Tobias
    Fegert, Joerg M.
    Hellenschmidt, Tobias
    Kaess, Michael
    Koelch, Michael
    Renner, Tobias
    Rexroth, Christian
    Walitza, Susanne
    Schulte-Koerne, Gerd
    Romanos, Marcel
    Egberts, Karin Maria
    Magni, Paolo
    PHARMACEUTICS, 2023, 15 (09)
  • [5] Therapeutic drug monitoring (TDM) in children and adolescents during sertraline therapy
    Klampfl, K.
    Fleischmann, Y.
    Wewetzer, Ch
    Pfuhlmann, B.
    Mehler-Wex, C.
    Gerlach, M.
    PHARMACOPSYCHIATRY, 2011, 44 (06)
  • [6] Duloxetine Serum Concentrations and Clinical Effects. Data from a Therapeutic Drug Monitoring (TDM) Survey
    Waldschmitt, C.
    Vogel, F.
    Pfuhlmann, B.
    Hiemke, C.
    PHARMACOPSYCHIATRY, 2009, 42 (05) : 189 - 193
  • [7] Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) service
    Waldschmitt, C.
    Vogel, F.
    Maurer, C.
    Hiemke, C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 191 - 191
  • [8] HIGHLY VARIABLE PLASMA CONCENTRATIONS OF VORICONAZOLE IN CHILDREN UNDERGOING HSCT: THERAPEUTIC DRUG MONITORING (TDM) IS INDISPENSABLE
    Bierings, M. B.
    Wolfs, T.
    Tessa, V
    Jaap, B. J.
    Imke, B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S228 - S229
  • [9] Voriconazole therapeutic drug monitoring: results of a prematurely discontinued randomized multicenter trial
    Neofytos, D.
    Ostrander, D.
    Shoham, S.
    Laverdiere, M.
    Hiemenz, J.
    Nguyen, H.
    Clarke, W.
    Brass, L.
    Lu, N.
    Marr, K. A.
    TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (06) : 831 - 837
  • [10] DETERMINANTS OF VERY LOW VORICONAZOLE CONCENTRATIONS IN ROUTINE THERAPEUTIC DRUG MONITORING (TDM)
    Hassan, A.
    Burhenne, J.
    Riedel, K. -D.
    Weiss, J.
    Mikus, G.
    Haefeli, W. E.
    Czock, D.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 : 8 - 8
12345